• QuantX Becomes the First CADx Device Cleared by US FDA!!!

    Quantitative Insights, Inc. (QI) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its QuantX system, an imaging based platform that uses artificial intelligence for the evaluation of breast lesions. This is the first ever device cleared as a computer-assisted diagnostic (CADx) device by the FDA.

    QuantX is one of the many novel products and product features that the company intends to bring to market to improve both the accuracy and cost of breast cancer diagnosis and therapy. QuantX is a modular software solution that runs on a single workstation connected to any DICOM-conformant system.

  • Successful Study!

    The study’s primary endpoint was achieved with statistical significance.

    A total of 19 readers completed the study which demonstrated a statistically significant increase in radiologist’s performance when compared to interpretations using the tools available in existing commercial systems. Performance improved for all of the readers in the study, and the study demonstrated a reduction in false negatives (i.e. missed cancers) by 39%.

    Read More…

  • Machine Learning in Radiology

    Combining machine learning and a big data derived historic reference case database.

  • Contact Us

    Contact us for more information!

    Contact Us
  • Quantitative Insights, Inc. (QI) was formed to realize the clinical and commercial value of QuantX, a Computer-Aided Diagnosis system to aid Radiologists in more accurate diagnosis of breast cancer. Developed in the labs and clinics of the University of Chicago to improve outcomes while, at the same time, significantly reducing costs, QuantX addresses critical needs of clinicians, practice administrators and patients… Read More

  • Stay Up To Date

    Sign up with your email address to receive news and updates.

    We respect your privacy. We'll never share or sell your email.

  • Meet Our Team

Contact Us For More Information Contact Us